Patents by Inventor Valdimir Podust

Valdimir Podust has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS FOR OVARIAN CANCER: Beta 2 MICROGLOBULIN
    Publication number: 20150153348
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: December 4, 2013
    Publication date: June 4, 2015
    Applicant: Vermillion, Inc.
    Inventors: Eric T. Fung, Enrique Dalmasso, Valdimir Podust, Zheng Wang
  • METHODS OF DETECTING A FRAGMENT OF NEUROSECRETORY PROTEIN VGF FOR DIAGNOSING ALZHEIMER'S DISEASE
    Publication number: 20110294865
    Abstract: The present invention provides a neurosecretory protein VGF peptide useful in qualifying Alzheimer's disease status in a patient. In particular, this peptide and modified forms thereof may be used to classify a subject sample as Alzheimer's disease or non-Alzheimer's disease. The peptide biomarker can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: July 2, 2010
    Publication date: December 1, 2011
    Applicant: VERMILLION, INC.
    Inventors: Huw Alun Davies, Kaj Blennow, James McGuire, Valdimir Podust, Anja Hviid Simonsen
  • Biomarkers for Ovarian Cancer: B2 Microglobulin
    Publication number: 20100197561
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: June 23, 2006
    Publication date: August 5, 2010
    Applicant: Ciphergen Biosystems, Inc.
    Inventors: Eric Thomas Fung, Enrique Dalmasso, Valdimir Podust, Zheng Wang
  • Biomaker for ovarian and endometrial cancer: hepcidin
    Publication number: 20100068724
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status as well as endometrical cancer status in a patient. In particular, it has been found that hepcidin is a biomarker for both ovarian cancer and endometrial cancer and that a panel of biomarkers, including hepcidin, transthyretin and optionally other markers are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: March 9, 2009
    Publication date: March 18, 2010
    Applicants: Vermilllion, Inc., The Johns Hopkins University, Board of Regents, The University of Texas System
    Inventors: Eric T. Fung, Robert Bast, Daniel W. Chan, Jin Song, Valdimir Podust, Zhen Zhang
  • Biomarker for ovarian and endometrial cancer: hepcidin
    Patent number: 7510842
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status as well as endometrical cancer status in a patient. In particular, it has been found that hepcidin is a biomarker for both ovarian cancer and endometrial cancer and that a panel of biomarkers, including hepcidin, transthyretin and optionally other markers are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Grant
    Filed: March 10, 2006
    Date of Patent: March 31, 2009
    Assignees: Vermilllion, Inc., The John Hopkins University, Board of Regents, The University of Texas System
    Inventors: Valdimir Podust, Zhen Zhang, Eric T. Fung, Robert Bast, Daniel W. Chan, Jin Song
  • Biomarker for ovarian and endometrial cancer: hepcidin
    Publication number: 20070054329
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status as well as endometrical cancer status in a patient. In particular, it has been found that hepcidin is a biomarker for both ovarian cancer and endometrial cancer and that a panel of biomarkers, including hepcidin, transthyretin and optionally other markers are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: March 10, 2006
    Publication date: March 8, 2007
    Applicants: Ciphergen Biosystems, Inc., The Johns Hopkins University, Board of Regents, The University of Texas System
    Inventors: Eric Fung, Robert Bast, Daniel Chan, Jin Song, Valdimir Podust, Zhen Zhang